These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 21234620)
1. Gene expression profiling of meningiomas: current status after a decade of microarray-based transcriptomic studies. Aarhus M; Lund-Johansen M; Knappskog PM Acta Neurochir (Wien); 2011 Mar; 153(3):447-56. PubMed ID: 21234620 [TBL] [Abstract][Full Text] [Related]
2. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype. Fèvre-Montange M; Champier J; Durand A; Wierinckx A; Honnorat J; Guyotat J; Jouvet A Int J Oncol; 2009 Dec; 35(6):1395-407. PubMed ID: 19885562 [TBL] [Abstract][Full Text] [Related]
3. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Wrobel G; Roerig P; Kokocinski F; Neben K; Hahn M; Reifenberger G; Lichter P Int J Cancer; 2005 Mar; 114(2):249-56. PubMed ID: 15540215 [TBL] [Abstract][Full Text] [Related]
4. Comparative proteomic profiles of meningioma subtypes. Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085 [TBL] [Abstract][Full Text] [Related]
5. [Meningiomas: new prognostic factors]. Sanz Esponera J An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Watson MA; Gutmann DH; Peterson K; Chicoine MR; Kleinschmidt-DeMasters BK; Brown HG; Perry A Am J Pathol; 2002 Aug; 161(2):665-72. PubMed ID: 12163391 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific. Jun P; Hong C; Lal A; Wong JM; McDermott MW; Bollen AW; Plass C; Held WA; Smiraglia DJ; Costello JF Neuro Oncol; 2009 Aug; 11(4):414-22. PubMed ID: 19001526 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses. Kishida Y; Natsume A; Kondo Y; Takeuchi I; An B; Okamoto Y; Shinjo K; Saito K; Ando H; Ohka F; Sekido Y; Wakabayashi T Carcinogenesis; 2012 Feb; 33(2):436-41. PubMed ID: 22102699 [TBL] [Abstract][Full Text] [Related]
10. Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas. Pérez-Magán E; Rodríguez de Lope A; Ribalta T; Ruano Y; Campos-Martín Y; Pérez-Bautista G; García JF; García-Claver A; Fiaño C; Hernández-Moneo JL; Mollejo M; Meléndez B Neuro Oncol; 2010 Dec; 12(12):1278-90. PubMed ID: 20685720 [TBL] [Abstract][Full Text] [Related]
11. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression. Sayagués JM; Tabernero MD; Maíllo A; Trelles O; Espinosa AB; Sarasquete ME; Merino M; Rasillo A; Vera JF; Santos-Briz A; de Alava E; Garcia-Macias MC; Orfao A J Neuropathol Exp Neurol; 2006 May; 65(5):445-54. PubMed ID: 16772868 [TBL] [Abstract][Full Text] [Related]
12. Comparison of gene expression profiles between frozen original meningiomas and primary cultures of the meningiomas by GeneChip. Sasaki T; Hankins GR; Helm GA Neurosurgery; 2003 Apr; 52(4):892-8; discussion 898-9. PubMed ID: 12657186 [TBL] [Abstract][Full Text] [Related]
13. Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas. Schulten HJ; Hussein D PLoS One; 2019; 14(5):e0215452. PubMed ID: 31083655 [TBL] [Abstract][Full Text] [Related]
14. Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status. Goutagny S; Yang HW; Zucman-Rossi J; Chan J; Dreyfuss JM; Park PJ; Black PM; Giovannini M; Carroll RS; Kalamarides M Clin Cancer Res; 2010 Aug; 16(16):4155-64. PubMed ID: 20682713 [TBL] [Abstract][Full Text] [Related]
15. Histological classification and molecular genetics of meningiomas. Riemenschneider MJ; Perry A; Reifenberger G Lancet Neurol; 2006 Dec; 5(12):1045-54. PubMed ID: 17110285 [TBL] [Abstract][Full Text] [Related]
16. Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression. Schulten HJ; Hussein D; Al-Adwani F; Karim S; Al-Maghrabi J; Al-Sharif M; Jamal A; Al-Ghamdi F; Baeesa SS; Bangash M; Chaudhary A; Al-Qahtani M PLoS One; 2016; 11(4):e0153681. PubMed ID: 27096627 [TBL] [Abstract][Full Text] [Related]
17. DNA methylation profiling demonstrates superior diagnostic classification to RNA-sequencing in a case of metastatic meningioma. Vasudevan HN; Castro MRH; Lee JC; Villanueva-Meyer JE; Bush NAO; McDermott MW; Solomon DA; Perry A; Magill ST; Raleigh DR Acta Neuropathol Commun; 2020 Jun; 8(1):82. PubMed ID: 32517746 [TBL] [Abstract][Full Text] [Related]